Axogen Inc
(LTS:0HKD)
$
15.02
0.448 (3.07%)
Market Cap: 653.08 Mil
Enterprise Value: 697.41 Mil
PE Ratio: 0
PB Ratio: 6.57
GF Score: 60/100 AxoGen Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022 / 10:20AM GMT
Release Date Price:
$13.19
Mike Sarcone
UBS Securities LLC - Analyst
My name is Mike Sarcone. I work on the US Medical Supplies and Devices team. And with us today, we're happy to have Axogen. And from the team, we've got Karen Zaderej, Chairperson, President, and CEO; and Pete Mariani, Executive Vice President and CFO.
Karen, Pete, thank you for joining us.
Karen Zaderej
Axogen, Inc. - Chairman, CEO & President
Thank you.
Pete Mariani
Axogen, Inc. - EVP & CFO
Thank you.
Questions & Answers
Mike Sarcone
UBS Securities LLC - Analyst
So I guess just to kick it off for those who are newer to the story, do you think you can give us a quick overview of Axogen's product offering and applications and the value proposition versus standard of care? And then just secondly to that, can you touch on the progress you've made over the past few years in terms of driving adoption?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot